Cytokines: Oncostatin M – a new target in IBD?

Nature Reviews Immunology 17, 280 (2017). doi:10.1038/nri.2017.45 Author: Yvonne Bordon Oncostatin M promotes intestinal inflammation and can predict responsiveness to anti-TNF therapy in patients with inflammatory bowel diseases.
Source: Nature Reviews Immunology - Category: Allergy & Immunology Authors: Tags: Research Highlight Source Type: research